Ocean Biomedical Stock Performance
| OCEA Stock | 0 0.0001 7.69% |
Ocean Biomedical holds a performance score of 13 on a scale of zero to a hundred. The company holds a Beta of 11.69, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ocean Biomedical will likely underperform. Use Ocean Biomedical coefficient of variation, sortino ratio, potential upside, as well as the relationship between the jensen alpha and maximum drawdown , to analyze future returns on Ocean Biomedical.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Ocean Biomedical are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, Ocean Biomedical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Ocean |
Ocean Biomedical Relative Risk vs. Return Landscape
If you would invest 0.70 in Ocean Biomedical on October 9, 2025 and sell it today you would lose (0.58) from holding Ocean Biomedical or give up 82.86% of portfolio value over 90 days. Ocean Biomedical is currently generating 13.0983% in daily expected returns and assumes 75.3827% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Ocean, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Ocean Biomedical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ocean Biomedical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Ocean Biomedical, and traders can use it to determine the average amount a Ocean Biomedical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1738
| Best Portfolio | Best Equity | OCEA | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Ocean Biomedical is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ocean Biomedical by adding it to a well-diversified portfolio.
Ocean Biomedical Fundamentals Growth
Ocean Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ocean Biomedical, and Ocean Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ocean Pink Sheet performance.
| Return On Asset | -0.74 | |||
| Current Valuation | 18.14 M | |||
| Shares Outstanding | 166.01 M | |||
| Price To Book | 100.67 X | |||
| EBITDA | (957.74 K) | |||
| Total Debt | 16.3 M | |||
| Book Value Per Share | (2.80) X | |||
| Cash Flow From Operations | (4.18 M) | |||
| Earnings Per Share | (0.34) X | |||
| Total Asset | 902 K | |||
| Retained Earnings | (205.53 M) | |||
About Ocean Biomedical Performance
By analyzing Ocean Biomedical's fundamental ratios, stakeholders can gain valuable insights into Ocean Biomedical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ocean Biomedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ocean Biomedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Ocean Biomedical performance evaluation
Checking the ongoing alerts about Ocean Biomedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ocean Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ocean Biomedical is way too risky over 90 days horizon | |
| Ocean Biomedical has some characteristics of a very speculative penny stock | |
| Ocean Biomedical appears to be risky and price may revert if volatility continues | |
| Ocean Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (9.48 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ocean Biomedical generates negative cash flow from operations | |
| About 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Should Investors Be Concerned About This Pharmaceutical Giants Latest Clinical Trial |
- Analyzing Ocean Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ocean Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Ocean Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ocean Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ocean Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ocean Biomedical's pink sheet. These opinions can provide insight into Ocean Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ocean Pink Sheet analysis
When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |